Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenghuang Ketong Ointment
- Development stage
- Phase 2
- Lead developer
- Chinese PLA General Hospital
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical
01
Overview
Shenghuang Ketong Ointment is a topical pharmaceutical preparation developed by the Chinese People's Liberation Army General Hospital. It is currently in Phase 2 clinical development, with its primary indication being the treatment of herpes zoster (shingles). The specific mechanism of action and active ingredients have not been disclosed in public sources. The ointment represents an investigational therapy aimed at alleviating symptoms associated with herpes zoster, such as pain and skin lesions[1][6].
- Brand names
- Shenghuang Ketong Ointment
- Other names
- Shenghuang Ketong
Beyond the preview
Go deeper on Shenghuang Ketong Ointment.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenghuang Ketong Ointment.